Annual Drug Patent Expirations for SILENOR
Silenor is a drug marketed by Currax and is included in one NDA. It is available from three suppliers. There are twelve patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for SILENOR.
This drug has sixteen patent family members in four countries.
The generic ingredient in SILENOR is doxepin hydrochloride. Three suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
